Quantitative sensory profiles of upper extremity chemotherapy induced peripheral neuropathy: Are there differences in sensory profiles for neuropathic versus nociceptive pain?

References

• Starobova H, Vetter I. Pathophysiology of chemotherapy-induced peripheral neuropathy. Front Mol Neurosci. 2017;10:174. doi:10.3389/fnmol.2017.00174.
   PubMed Web of Science ®Google Scholar
• Kerckhove N, Collin A, Conde S, Chaleteix C, Pezet D, Balayssac D. Long-term effects, pathophysiological mechanisms, and risk factors of chemotherapy-induced peripheral neuropathies: a comprehensive literature review. Front Pharmacol. 2017;8:86. doi:10.3389/fphar.2017.00086.
   PubMed Web of Science ®Google Scholar
• Speck RM, Sammel MD, Farrar JT, Hennessy S, Mao JJ, Stineman MG, DeMichele A. Impact of chemotherapy-induced peripheral neuropathy on treatment delivery in nonmetastatic breast cancer. J Oncol Pract. 2013;9(5):e234–40. doi:10.1200/JOP.2012.000863.
   PubMedGoogle Scholar
• Park SB, Lin CS, Krishnan AV, Friedlander ML, Lewis CR, Kiernan MC. Early, progressive, and sustained dysfunction of sensory axons underlies paclitaxel-induced neuropathy. Muscle Nerve. 2011;43(3):367–74. doi:10.1002/mus.21874.
   PubMed Web of Science ®Google Scholar
• Hershman DL, Lacchetti C, Dworkin RH, Lavoie Smith EM, Bleeker J, Cavaletti G, Chauhan C, Gavin P, Lavino A, Lustberg MB, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American society of clinical oncology clinical practice guideline. J Clin Oncol. 2014;32(18):1941–67. doi:10.1200/JCO.2013.54.0914.
   PubMed Web of Science ®Google Scholar
• Smith EM, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T, Bressler LR, Fadul CE, Knox C, Le-Lindqwister N, et al. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA. 2013;309(13):1359–67. doi:10.1001/jama.2013.2813.
   PubMed Web of Science ®Google Scholar
• Moulin D, Boulanger A, Clark AJ, Clarke H, Dao T, Finley GA, Furlan A, Gilron I, Gordon A, Morley-Forster PK, et al. Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian pain society. Pain Res Manage. 2014;19(6):328–35. doi:10.1155/2014/754693.
   PubMed Web of Science ®Google Scholar
• Grisold W, Cavaletti G, Windebank AJ. Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro-oncology. 2012;14(Suppl 4):iv45–54. doi:10.1093/neuonc/nos203.
   PubMed Web of Science ®Google Scholar
• Brewer JR, Morrison G, Dolan ME, Fleming GF. Chemotherapy-induced peripheral neuropathy: current status and progress. Gynecol Oncol. 2016;140(1):176–83. doi:10.1016/j.ygyno.2015.11.011.
   PubMed Web of Science ®Google Scholar
• Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, Colvin LA, Fallon M. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain. 2014;155(12):2461–70. doi:10.1016/j.pain.2014.09.020.
   PubMed Web of Science ®Google Scholar
• Edwards RR, Haythornthwaite JA, Tella P, Max MB, Raja S. Basal heat pain thresholds predict opioid analgesia in patients with postherpetic neuralgia. Anesthesiology. 2006;104(6):1243–48. doi:10.1097/00000542-200606000-00020.
   PubMed Web of Science ®Google Scholar
• Cruz-Almeida Y, Fillingim RB. Can quantitative sensory testing move us closer to mechanism-based pain management? Pain Med. 2014;15(1):61–72. doi:10.1111/pme.12230.
   PubMed Web of Science ®Google Scholar
• Attal N, Bouhassira D, Baron R, Dostrovsky J, Dworkin RH, Finnerup N, Gourlay G, Haanpaa M, Raja S, Rice AS, et al. Assessing symptom profiles in neuropathic pain clinical trials: can it improve outcome? Eur J Pain. 2011;15(5):441–43. doi:10.1016/j.ejpain.2011.03.005.
   PubMed Web of Science ®Google Scholar
• Bennett MI, Smith BH, Torrance N, Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain. 2005;6(3):149–58. doi:10.1016/j.jpain.2004.11.007.
   PubMed Web of Science ®Google Scholar
• Perez C, Sanchez-Martinez N, Ballesteros A, Blanco T, Collazo A, Gonzalez F, Villoria J. Prevalence of pain and relative diagnostic performance of screening tools for neuropathic pain in cancer patients: a cross-sectional study. Eur J Pain. 2015;19(6):752–61. doi:10.1002/ejp.598.
   PubMed Web of Science ®Google Scholar
• Hardy J, Quinn S, Fazekas B, Agar M, Currow D. Can the LANSS scale be used to classify pain in chronic cancer pain trials? Supportive Care Cancer. 2013;21(12):3387–91. doi:10.1007/s00520-013-1921-5.
   PubMed Web of Science ®Google Scholar
• Gutierrez-Gutierrez G, Sereno M, Miralles A, Casado-Saenz E, Gutierrez-Rivas E. Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies. Clin Transl Oncol. 2010;12(2):81–91. doi:10.1007/S12094-010-0474-z.
   PubMed Web of Science ®Google Scholar
• Beaton DE, Katz JN, Fossel AH, Wright JG, Tarasuk V, Bombardier C. Measuring the whole or the parts? validity, reliability, and responsiveness of the disabilities of the arm, shoulder and hand outcome measure in different regions of the upper extremity. J Hand Ther. 2001;14:128–46.
   PubMedGoogle Scholar
• Harrington S, Michener LA, Kendig T, Miale S, George SZ. Patient-reported upper extremity outcome measures used in breast cancer survivors: a systematic review. Arch Phys Med Rehabil. 2014;95(1):153–62. doi:10.1016/j.apmr.2013.07.022.
   PubMed Web of Science ®Google Scholar
• Hedeker D, Toit S, Demirtas H, Gibbons RD. A note on marginalization of regression parameters from mixed models of binary outcomes. Biometrics. 2018;74(1):354–61. doi:10.1111/biom.12707.
   PubMed Web of Science ®Google Scholar
• SAS Institute Inc. SAS/STAT software, version 14.1 of the SAS System for Windows. Cary, NC: SAS Institute Inc.
   Google Scholar
• Gonzalez-Duarte A, Lem-Carrillo M, Guerrero-Torres L. Normative values of quantitative sensory testing in Hispanic Latino population. Brain Behav. 2016;6(7):e00466. doi:10.1002/brb3.466.
   PubMed Web of Science ®Google Scholar
• Hong JS, Tian J, Wu LH. The influence of chemotherapy-induced neurotoxicity on psychological distress and sleep disturbance in cancer patients. Curr Oncol. 2014;21(4):174–80. doi:10.3747/co.21.1984.
   PubMed Web of Science ®Google Scholar
• Pike CT, Birnbaum HG, Muehlenbein CE, Pohl GM, Natale RB. Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer. Chemother Res Pract. 2012;2012:913848. doi:10.1155/2012/913848.
   PubMedGoogle Scholar
• Han Y, Smith MT. Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN). Front Pharmacol. 2013;4:156. doi:10.3389/fphar.2013.00156.
   PubMed Web of Science ®Google Scholar
• Jardin I, Lopez JJ, Diez R, Sanchez-Collado J, Cantonero C, Albarran L, Woodard GE, Redondo PC, Salido GM, Smani T, et al. TRPs in pain sensation. Front Physiol. 2017;8:392. doi:10.3389/fphys.2017.00392.
   PubMed Web of Science ®Google Scholar
• Lees JG, Makker PG, Tonkin RS, Abdulla M, Park SB, Goldstein D, Moalem-Taylor G. Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy. Eur J Cancer. 2017;73:22–29. doi:10.1016/j.ejca.2016.12.006.
   PubMed Web of Science ®Google Scholar
• Skaper SD, Facci L, Zusso M, Giusti P. Neuroinflammation, mast cells, and glia: dangerous liaisons. Neuroscientist. 2017;23(5):478–98. doi:10.1177/1073858416687249.
   PubMed Web of Science ®Google Scholar
• Fernandes J, Kumar S. Effect of lower limb closed kinematic chain exercises on balance in patients with chemotherapy-induced peripheral neuropathy: a pilot study. Int J Rehabil Res. 2016;39(4):368–71. doi:10.1097/MRR.0000000000000196.
   PubMed Web of Science ®Google Scholar
• Fernandes V, Sharma D, Vaidya SPAS, Guan Y, Kalia K, Tiwari V. Cellular and molecular mechanisms driving neuropathic pain: recent advancements and challenges. Expert Opin Ther Targets. 2018;22(2):131–42. doi:10.1080/14728222.2018.1420781.
   PubMed Web of Science ®Google Scholar
• Udall M, Kudel I, Cappelleri JC, Sadosky A, King-Concialdi K, Parsons B, Hlavacek P, Hopps M, Salomon PA, Dibonaventura MD, et al. Epidemiology of physician-diagnosed neuropathic pain in Brazil. J Pain Res. 2019;12:243–53. doi:10.2147/JPR.S160504.
   PubMed Web of Science ®Google Scholar
• Kudel I, Hopps M, Cappelleri JC, Sadosky A, King-Concialdi K, Liebert R, Parsons B, Hlavacek P, Alexander AH, Dibonaventura MD, et al. Characteristics of patients with neuropathic pain syndromes screened by the painDETECT questionnaire and diagnosed by physician exam. J Pain Res. 2019;12:255–68. doi:10.2147/JPR.S160513.
   PubMed Web of Science ®Google Scholar
• Salman Roghani R, Delbari A, Asadi-Lari M, Rashedi V, Lökk J. Neuropathic pain prevalence of older adults in an urban area of Iran: a population-based study. Pain Res Treat. 2019;2019.
   Web of Science ®Google Scholar
• Moloney N, Beales D, Azoory R, Hübscher M, Waller R, Gibbons R, Rebbeck T. Are measures of pain sensitivity associated with pain and disability at 12-month follow up in chronic neck pain? Musculoskeletal Care. 2018;16(4):415–24. doi:10.1002/msc.1247.
   PubMed Web of Science ®Google Scholar
• Razmjou H, Woodhouse LJ, Holtby R. Neuropathic pain after shoulder arthroplasty: prevalence, impact on physical and mental function, and demographic determinants. Physiother Canada. 2018;70(3):212–20. doi:10.3138/ptc.2016-99.
   PubMed Web of Science ®Google Scholar
• Shaygan M, Böger A, Kröner-Herwig B. Predicting factors of outcome in multidisciplinary treatment of chronic neuropathic pain. J Pain Res. 2018;11:2433–43. doi:10.2147/JPR.S175817.
   PubMed Web of Science ®Google Scholar
• Cioroiu C, Weimer LH. Update on chemotherapy-induced peripheral neuropathy. Curr Neurol Neurosci Rep. 2017;17(6):47-017-0757-7. doi:10.1007/s11910-017-0757-7.
   PubMed Web of Science ®Google Scholar
• Kandula T, Farrar MA, Kiernan MC, Krishnan AV, Goldstein D, Horvath L, Grimison P, Boyle F, Baron-Hay S, Park SB. Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer. Clin Neurophysiol. 2017;128(7):1166–75. doi:10.1016/j.clinph.2017.04.009.
   PubMed Web of Science ®Google Scholar
• Eckhoff L, Feddersen S, Knoop AS, Ewertz M, Bergmann TK. Docetaxel-induced neuropathy: a pharmacogenetic case-control study of 150 women with early-stage breast cancer. Acta Oncol. 2015;54(4):530–37. doi:10.3109/0284186X.2014.969846.
   PubMed Web of Science ®Google Scholar
• Kus T, Aktas G, Kalender ME, Sevinc A, Kul S, Suner A, Ulker E, Camci C. Taxane-induced peripheral sensorial neuropathy in cancer patients is associated with duration of diabetes mellitus: a single-center retrospective study. Supportive Care Cancer. 2016;24(3):1175–79. doi:10.1007/s00520-015-2898-z.
   PubMed Web of Science ®Google Scholar
• DiBonaventura MD, Sadosky A, Concialdi K, Hopps M, Kudel I, Parsons B, Cappelleri JC, Hlavacek P, Alexander AH, Stacey BR, et al. The prevalence of probable neuropathic pain in the US: results from a multimodal general-population health survey. J Pain Res. 2017;10:2525–38. doi:10.2147/JPR.S127014.
   PubMed Web of Science ®Google Scholar
• Bennett IM, Rayment IC, Hjermstad IM, Aass IN, Caraceni IA, Kaasa IS. Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review. Pain. 2012;153(2):359–65. doi:10.1016/j.pain.2011.10.028.
   PubMed Web of Science ®Google Scholar
• Ilhan E, Chee E, Hush J, Moloney N. The prevalence of neuropathic pain is high after treatment for breast cancer: a systematic review. Pain. 2017;158(11):2082–91. doi:10.1097/j.pain.0000000000001004.
   PubMed Web of Science ®Google Scholar
• Stubblefield MD, McNeely ML, Alfano CM, Mayer DK. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy. Cancer. 2012;118(8 Suppl):2250–60. doi:10.1002/cncr.27463.
   PubMed Web of Science ®Google Scholar
• Upton AR, McComas AJ. The double crush in nerve entrapment syndromes. Lancet. 1973;2(7825):359–62. doi:10.1016/s0140-6736(73)93196-6.
   PubMed Web of Science ®Google Scholar
• Schmid AB, Coppieters MW. The double crush syndrome revisited–a Delphi study to reveal current expert views on mechanisms underlying dual nerve disorders. Man Ther. 2011;16(6):557–62. doi:10.1016/j.math.2011.05.005.
   PubMed Web of Science ®Google Scholar
• Vinik A, Mehrabyan A, Colen L, Boulton A. Focal entrapment neuropathies in diabetes. Diabetes Care. 2004;27(7):1783–88. doi:10.2337/diacare.27.7.1783.
   PubMed Web of Science ®Google Scholar
• Kelley S, Jull G. Breast surgery and neural tissue mechanosensitivity. Aust J Physiother. 1998;44:31–37.
   PubMedGoogle Scholar
• Hayes SC, Johansson K, Stout NL, Prosnitz R, Armer JM, Gabram S, Schmitz KH. Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care. Cancer. 2012;118(8 Suppl):2237–49. doi:10.1002/cncr.27467.
   PubMed Web of Science ®Google Scholar